Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2α—Ve-cadherin pathway

Daniel Rand; Orly Ravid; Dana Atrakchi; Hila Israelov; Yael Bresler; Chen Shemesh; Liora Omesi; Sigal Liraz-Zaltsman; Fabien Gosselet; Taber S. Maskrey; Michal Schnaider Beeri; Peter Wipf; Itzik Cooper

doi:10.3390/pharmaceutics13030311

Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2α—Ve-cadherin pathway

Daniel Rand, Orly Ravid, Dana Atrakchi, Hila Israelov, Yael Bresler, Chen Shemesh, Liora Omesi, Sigal Liraz-Zaltsman, Fabien Gosselet, Taber S. Maskrey, Michal Schnaider Beeri, Peter Wipf, Itzik Cooper

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Abstract

The objective of this study was to investigate the molecular response to damage at the blood brain barrier (BBB) and to elucidate critical pathways that might lead to effective treatment in central nervous system (CNS) pathologies in which the BBB is compromised. We have used a human, stem-cell derived in-vitro BBB injury model to gain a better understanding of the mechanisms controlling BBB integrity. Chemical injury induced by exposure to an organophosphate re-sulted in rapid lipid peroxidation, initiating a ferroptosis-like process. Additionally, mitochondrial ROS formation (MRF) and increase in mitochondrial membrane permeability were induced, leading to apoptotic cell death. Yet, these processes did not directly result in damage to barrier functionality, since blocking them did not reverse the increased permeability.

Original language	English
Article number	311
Pages (from-to)	1-24
Number of pages	24
Journal	Pharmaceutics
Volume	13
Issue number	3
DOIs	https://doi.org/10.3390/pharmaceutics13030311
State	Published - Mar 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2021 by the author. Licensee MDPI, Basel, Switzerland.

Funding

Funding: This work was mostly supported by the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense grant no. 11816372 for IC who is also supported by the Nehemia Rubin Excellence in Biomedical Research—The TELEM Program supported by the Aaron Gutwirth Fund and by a Ministry of Science and Technology grant no. 3-13576.

Funders	Funder number
Aaron Gutwirth Fund
Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense	11816372
Nehemia Rubin Excellence in Biomedical Research
Ministry of science and technology, Israel	3-13576

Keywords

Blood-brain barrier
DFO
HIF2α
Iron
Ve-cadherin

Access to Document

10.3390/pharmaceutics13030311

Cite this

Rand, D., Ravid, O., Atrakchi, D., Israelov, H., Bresler, Y., Shemesh, C., Omesi, L., Liraz-Zaltsman, S., Gosselet, F., Maskrey, T. S., Beeri, M. S., Wipf, P., & Cooper, I. (2021). Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2α—Ve-cadherin pathway. Pharmaceutics, 13(3), 1-24. Article 311. https://doi.org/10.3390/pharmaceutics13030311

@article{85ffd5850c5941949e1141ffa1ce75fb,

title = "Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2α—Ve-cadherin pathway",

abstract = "The objective of this study was to investigate the molecular response to damage at the blood brain barrier (BBB) and to elucidate critical pathways that might lead to effective treatment in central nervous system (CNS) pathologies in which the BBB is compromised. We have used a human, stem-cell derived in-vitro BBB injury model to gain a better understanding of the mechanisms controlling BBB integrity. Chemical injury induced by exposure to an organophosphate re-sulted in rapid lipid peroxidation, initiating a ferroptosis-like process. Additionally, mitochondrial ROS formation (MRF) and increase in mitochondrial membrane permeability were induced, leading to apoptotic cell death. Yet, these processes did not directly result in damage to barrier functionality, since blocking them did not reverse the increased permeability.",

keywords = "Blood-brain barrier, DFO, HIF2α, Iron, Ve-cadherin",

author = "Daniel Rand and Orly Ravid and Dana Atrakchi and Hila Israelov and Yael Bresler and Chen Shemesh and Liora Omesi and Sigal Liraz-Zaltsman and Fabien Gosselet and Maskrey, {Taber S.} and Beeri, {Michal Schnaider} and Peter Wipf and Itzik Cooper",

note = "Publisher Copyright: {\textcopyright} 2021 by the author. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = mar,

doi = "10.3390/pharmaceutics13030311",

language = "אנגלית",

volume = "13",

pages = "1--24",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "3",

}

TY - JOUR

T1 - Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2α—Ve-cadherin pathway

AU - Rand, Daniel

AU - Ravid, Orly

AU - Atrakchi, Dana

AU - Israelov, Hila

AU - Bresler, Yael

AU - Shemesh, Chen

AU - Omesi, Liora

AU - Liraz-Zaltsman, Sigal

AU - Gosselet, Fabien

AU - Maskrey, Taber S.

AU - Beeri, Michal Schnaider

AU - Wipf, Peter

AU - Cooper, Itzik

PY - 2021/3

Y1 - 2021/3

N2 - The objective of this study was to investigate the molecular response to damage at the blood brain barrier (BBB) and to elucidate critical pathways that might lead to effective treatment in central nervous system (CNS) pathologies in which the BBB is compromised. We have used a human, stem-cell derived in-vitro BBB injury model to gain a better understanding of the mechanisms controlling BBB integrity. Chemical injury induced by exposure to an organophosphate re-sulted in rapid lipid peroxidation, initiating a ferroptosis-like process. Additionally, mitochondrial ROS formation (MRF) and increase in mitochondrial membrane permeability were induced, leading to apoptotic cell death. Yet, these processes did not directly result in damage to barrier functionality, since blocking them did not reverse the increased permeability.

AB - The objective of this study was to investigate the molecular response to damage at the blood brain barrier (BBB) and to elucidate critical pathways that might lead to effective treatment in central nervous system (CNS) pathologies in which the BBB is compromised. We have used a human, stem-cell derived in-vitro BBB injury model to gain a better understanding of the mechanisms controlling BBB integrity. Chemical injury induced by exposure to an organophosphate re-sulted in rapid lipid peroxidation, initiating a ferroptosis-like process. Additionally, mitochondrial ROS formation (MRF) and increase in mitochondrial membrane permeability were induced, leading to apoptotic cell death. Yet, these processes did not directly result in damage to barrier functionality, since blocking them did not reverse the increased permeability.

KW - Blood-brain barrier

KW - DFO

KW - HIF2α

KW - Iron

KW - Ve-cadherin

UR - http://www.scopus.com/inward/record.url?scp=85102748443&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics13030311

DO - 10.3390/pharmaceutics13030311

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 33670876

AN - SCOPUS:85102748443

SN - 1999-4923

VL - 13

SP - 1

EP - 24

JO - Pharmaceutics

JF - Pharmaceutics

IS - 3

M1 - 311

ER -

Endothelial iron homeostasis regulates blood-brain barrier integrity via the HIF2α—Ve-cadherin pathway

Abstract

Bibliographical note

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this